central precocious puberty.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Girls with central precocious puberty Having a BMI higher than 19 The age range of 7 to 9 years One year has passed since they were diagnosed with precocious puberty Being on medication for one year Being treated with Differlin drug Taking medication 1 ml every 28 days
Exclusion criteria
Exclusion criteria: having another illness taking another medicine having a special diet being active in another sport being connected to drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cytokines. Timepoint: Baseline, 12 weeks, 16 weeks. Method of measurement: Blood sampling and use of laboratory kits.;Stimulating hormones Sex hormones (lutein and follicle stimulating). Timepoint: Baseline, 12 weeks, 16 weeks. Method of measurement: Blood sampling and use of laboratory kits.;Signs of puberty (uterine and ovarian size, bone age). Timepoint: Baseline, 12 weeks, 16 weeks. Method of measurement: Ultrasound and Grolich and Pyle Atlas. | — |
Countries
Iran (Islamic Republic of)
Contacts
Bu-Ali Sina university